» Articles » PMID: 32071206

Integrated Functional Genomic Analyses of Klinefelter and Turner Syndromes Reveal Global Network Effects of Altered X Chromosome Dosage

Overview
Specialty Science
Date 2020 Feb 20
PMID 32071206
Citations 47
Authors
Affiliations
Soon will be listed here.
Abstract

In both Turner syndrome (TS) and Klinefelter syndrome (KS) copy number aberrations of the X chromosome lead to various developmental symptoms. We report a comparative analysis of TS vs. KS regarding differences at the genomic network level measured in primary samples by analyzing gene expression, DNA methylation, and chromatin conformation. X-chromosome inactivation (XCI) silences transcription from one X chromosome in female mammals, on which most genes are inactive, and some genes escape from XCI. In TS, almost all differentially expressed escape genes are down-regulated but most differentially expressed inactive genes are up-regulated. In KS, differentially expressed escape genes are up-regulated while the majority of inactive genes appear unchanged. Interestingly, 94 differentially expressed genes (DEGs) overlapped between TS and female and KS and male comparisons; and these almost uniformly display expression changes into opposite directions. DEGs on the X chromosome and the autosomes are coexpressed in both syndromes, indicating that there are molecular ripple effects of the changes in X chromosome dosage. Six potential candidate genes (, , , , , and ) for KS are identified on Xq, as well as candidate central genes on Xp for TS. Only promoters of inactive genes are differentially methylated in both syndromes while escape gene promoters remain unchanged. The intrachromosomal contact map of the X chromosome in TS exhibits the structure of an active X chromosome. The discovery of shared DEGs indicates the existence of common molecular mechanisms for gene regulation in TS and KS that transmit the gene dosage changes to the transcriptome.

Citing Articles

The transcriptomic landscape of monosomy X (45,X) during early human fetal and placental development.

Suntharalingham J, Del Valle I, Buonocore F, McGlacken-Byrne S, Brooks T, Ogunbiyi O Commun Biol. 2025; 8(1):249.

PMID: 39956831 PMC: 11830783. DOI: 10.1038/s42003-025-07699-4.


Elevated levels of neutrophils with a pro-inflammatory profile in Turner syndrome across karyotypes.

Just J, Ridder L, Johannsen E, Jensen J, Petersen M, Christensen H NPJ Genom Med. 2025; 10(1):9.

PMID: 39915521 PMC: 11803089. DOI: 10.1038/s41525-025-00467-7.


An extra X chromosome: dissecting its role in male fetal germ cell maturation.

Tang S, Zhang F, Wu Y Sci China Life Sci. 2025; .

PMID: 39856444 DOI: 10.1007/s11427-024-2825-3.


Immune Gene Expression Profiling in Individuals with Turner Syndrome, Graves' Disease, and a Healthy Female by Single-Cell RNA Sequencing: A Comparative Study.

Sim S, Baek I, Cho W, Jung M, Kim T, Suh B Cells. 2025; 14(2).

PMID: 39851522 PMC: 11764232. DOI: 10.3390/cells14020093.


Reproductive outcomes after preimplantation genetic testing in couples with sex chromosome abnormalities: a retrospective cohort study of 83 couples.

Yang T, Xiao M, Sun X, Li H J Assist Reprod Genet. 2024; 41(12):3415-3421.

PMID: 39476305 PMC: 11707093. DOI: 10.1007/s10815-024-03303-6.


References
1.
Tukiainen T, Villani A, Yen A, Rivas M, Marshall J, Satija R . Landscape of X chromosome inactivation across human tissues. Nature. 2017; 550(7675):244-248. PMC: 5685192. DOI: 10.1038/nature24265. View

2.
Bakalov V, Cheng C, Zhou J, Bondy C . X-chromosome gene dosage and the risk of diabetes in Turner syndrome. J Clin Endocrinol Metab. 2009; 94(9):3289-96. PMC: 2741724. DOI: 10.1210/jc.2009-0384. View

3.
Winge S, Dalgaard M, Jensen J, Graem N, Schierup M, Juul A . Transcriptome profiling of fetal Klinefelter testis tissue reveals a possible involvement of long non-coding RNAs in gonocyte maturation. Hum Mol Genet. 2017; 27(3):430-439. DOI: 10.1093/hmg/ddx411. View

4.
Rao S, Huntley M, Durand N, Stamenova E, Bochkov I, Robinson J . A 3D map of the human genome at kilobase resolution reveals principles of chromatin looping. Cell. 2014; 159(7):1665-80. PMC: 5635824. DOI: 10.1016/j.cell.2014.11.021. View

5.
Rajpathak S, Deobagkar D . Evidence for epigenetic alterations in Turner syndrome opens up feasibility of new pharmaceutical interventions. Curr Pharm Des. 2013; 20(11):1778-85. DOI: 10.2174/13816128113199990518. View